Immunopathogenesis of acute on chronic liver failure

Am J Transplant. 2024 May;24(5):724-732. doi: 10.1016/j.ajt.2024.02.001. Epub 2024 Feb 10.

Abstract

Acute-on-chronic liver failure is a well-established description of a high-mortality syndrome of chronic liver disease (usually cirrhosis) with organ failure. While the exact definition is under refinement, the accepted understanding of this entity is in patients with chronic liver disease and various organs in failure and where systemic inflammation is a major component of the pathobiology. There are limited therapies for a disease with such a poor prognosis, and while improvements in the critical care management and for very few patients, liver transplantation, mean 50% can survive to hospital discharge, rapid application of new therapies is required. Here we explain the current understanding of the immunologic abnormalities seen in acute-on-chronic liver failure across the innate and adaptive immune systems, the role of the hepatic cell death and the gut-liver axis, and recommendations for future research and treatment paradigms.

Keywords: acute-on-chronic liver failure; cirrhosis; immunology; organ failure.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-On-Chronic Liver Failure* / etiology
  • Acute-On-Chronic Liver Failure* / immunology
  • Humans
  • Immunity, Innate
  • Liver / immunology
  • Liver / pathology
  • Liver Transplantation